Evidence map›Paper›PMID 28031866›Full record

ReviewFuture science OA2015

Nitric oxide: a brief overview of chemical and physical properties relevant to therapeutic applications.

Jack R Lancaster

Abstract readReview
In one paragraph

Review in Future science OA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Repurposing of Chemotherapeutics to Combat COVID-19.Current topics in medicinal chemistry · 2022
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jack R LancasterDepartments of Pharmacology & Chemical Biology, Medicine, & Surgery, School of Medicine, University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA 15260, USA.

Funding

Biological Chemistry of Reactive Nitrogen Species Signaling in Cancer EtiologyR01CA131653 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LANCASTER, JACK R · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA131653
6 · The paper itself

Abstract

Nitric oxide (nitrogen monoxide, •NO) has been intensively studied by chemists and physicists for over 200 years and thus there is an extensive database of information that determines its biological actions. This is a very brief overview of the chemical and physical properties of •NO that are most relevant to Biology in general and to the development of •NO releasing materials in particular.

Indexed as

diffusionoxidation-reductionradicaltransition metals

Identifiers

PMID28031866
PMCPMC5137977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.